Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Christian Brander

18PUBLICATIONS
111CO-AUTHORS
Innate immunityEpidemiological methodsMajor global burdens of diseaseIndustrial molecular engineering of nucleic acids and proteinsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

Sort by Publication Date:
|Apr 27, 2026
Antiretroviral therapy blocks natural selection on protective and disease-susceptible HLA-B alleles in HIV-1 infection.

|Dec 08, 2025
Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._.

Lucia Bailón, Yovaninna Alarcón-Soto, José R Arribas

|Apr 08, 2025
In danger: HIV vaccine research and development in Europe.

Roger Tatoud, Yves Lévy, Roger Le Grand

|Mar 04, 2025
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial.

Lucia Bailón, José Moltó, Adrian Curran

|Jan 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.

Jesper D Gunst, Jesal Gohil, Johanthan Z Li

|Jul 23, 2024
Biotech's role in advancing HIV vaccine development.

Roger Tatoud, Christian Brander, Carey Hwang

Pageof 3

Frequent Collaborators

5 joint publications

Beatriz Mothe

3 joint publications

Samandhy Cedeño

3 joint publications

Roger Paredes

3 joint publications

Yovaninna Alarcón-Soto

3 joint publications

Tuixent Escribà

3 joint publications

Lucia Bailón

2 joint publications

Tomáš Hanke

2 joint publications

Bruna Oriol-Tordera

2 joint publications

Ian McGowan

2 joint publications

Miriam Rosás-Umbert

Frequent Collaborators

5 joint publications

Beatriz Mothe

3 joint publications

Samandhy Cedeño

3 joint publications

Roger Paredes

3 joint publications

Yovaninna Alarcón-Soto

Top Related Videos

A Restriction Enzyme Based Cloning Method to Assess the <em>In vitro</em> Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the <em>In vitro</em> Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on : Aug 31, 2014

15.2K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on : Oct 06, 2022

2.8K
Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

8.6K
See more related videos

Top Related Videos

A Restriction Enzyme Based Cloning Method to Assess the <em>In vitro</em> Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the <em>In vitro</em> Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on : Aug 31, 2014

15.2K
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on : Oct 06, 2022

2.8K
Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

8.6K
See more related videos